These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 24642426

  • 1. Limitations of Foxp3(+) Treg depletion following viral infection in DEREG mice.
    Christiaansen AF, Boggiatto PM, Varga SM.
    J Immunol Methods; 2014 Apr; 406():58-65. PubMed ID: 24642426
    [Abstract] [Full Text] [Related]

  • 2. Rapid rebound of the Treg compartment in DEREG mice limits the impact of Treg depletion on mycobacterial burden, but prevents autoimmunity.
    Berod L, Stüve P, Varela F, Behrends J, Swallow M, Kruse F, Krull F, Ghorbani P, Mayer CT, Hölscher C, Sparwasser T.
    PLoS One; 2014 Apr; 9(7):e102804. PubMed ID: 25050936
    [Abstract] [Full Text] [Related]

  • 3. Repeated Long-Term DT Application in the DEREG Mouse Induces a Neutralizing Anti-DT Antibody Response.
    Wang J, Siffert M, Spiliotis M, Gottstein B.
    J Immunol Res; 2016 Apr; 2016():1450398. PubMed ID: 28074191
    [Abstract] [Full Text] [Related]

  • 4. Transient Depletion of Foxp3+ Regulatory T Cells Selectively Promotes Aggressive β Cell Autoimmunity in Genetically Susceptible DEREG Mice.
    Watts D, Janßen M, Jaykar M, Palmucci F, Weigelt M, Petzold C, Hommel A, Sparwasser T, Bonifacio E, Kretschmer K.
    Front Immunol; 2021 Apr; 12():720133. PubMed ID: 34447385
    [Abstract] [Full Text] [Related]

  • 5. Deletion of Foxp3+ regulatory T cells in genetically targeted mice supports development of intestinal inflammation.
    Boehm F, Martin M, Kesselring R, Schiechl G, Geissler EK, Schlitt HJ, Fichtner-Feigl S.
    BMC Gastroenterol; 2012 Jul 31; 12():97. PubMed ID: 22849659
    [Abstract] [Full Text] [Related]

  • 6. Adjuvant effect of diphtheria toxin after mucosal administration in both wild type and diphtheria toxin receptor engineered mouse strains.
    Chapman TJ, Georas SN.
    J Immunol Methods; 2013 Dec 31; 400-401():122-6. PubMed ID: 24200744
    [Abstract] [Full Text] [Related]

  • 7. Conditional regulatory T-cell depletion releases adaptive immunity preventing carcinogenesis and suppressing established tumor growth.
    Teng MW, Ngiow SF, von Scheidt B, McLaughlin N, Sparwasser T, Smyth MJ.
    Cancer Res; 2010 Oct 15; 70(20):7800-9. PubMed ID: 20924111
    [Abstract] [Full Text] [Related]

  • 8. Depletion of Foxp3+ regulatory T cells increases severity of mechanical allodynia and significantly alters systemic cytokine levels following peripheral nerve injury.
    Lees JG, Duffy SS, Perera CJ, Moalem-Taylor G.
    Cytokine; 2015 Feb 15; 71(2):207-14. PubMed ID: 25461400
    [Abstract] [Full Text] [Related]

  • 9. Foxp3+ CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection.
    Fulton RB, Meyerholz DK, Varga SM.
    J Immunol; 2010 Aug 15; 185(4):2382-92. PubMed ID: 20639494
    [Abstract] [Full Text] [Related]

  • 10. Advantages of Foxp3(+) regulatory T cell depletion using DEREG mice.
    Mayer CT, Lahl K, Milanez-Almeida P, Watts D, Dittmer U, Fyhrquist N, Huehn J, Kopf M, Kretschmer K, Rouse B, Sparwasser T.
    Immun Inflamm Dis; 2014 Nov 15; 2(3):162-5. PubMed ID: 25505550
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Optimal isolation of functional Foxp3+ induced regulatory T cells using DEREG mice.
    Baru AM, Untucht C, Ganesh V, Hesse C, Mayer CT, Sparwasser T.
    PLoS One; 2012 Nov 15; 7(9):e44760. PubMed ID: 22957107
    [Abstract] [Full Text] [Related]

  • 13. In vivo depletion of FoxP3+ Tregs using the DEREG mouse model.
    Lahl K, Sparwasser T.
    Methods Mol Biol; 2011 Nov 15; 707():157-72. PubMed ID: 21287334
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease.
    Lahl K, Loddenkemper C, Drouin C, Freyer J, Arnason J, Eberl G, Hamann A, Wagner H, Huehn J, Sparwasser T.
    J Exp Med; 2007 Jan 22; 204(1):57-63. PubMed ID: 17200412
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma.
    Klages K, Mayer CT, Lahl K, Loddenkemper C, Teng MW, Ngiow SF, Smyth MJ, Hamann A, Huehn J, Sparwasser T.
    Cancer Res; 2010 Oct 15; 70(20):7788-99. PubMed ID: 20924102
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Limited role of regulatory T cells during acute Theiler virus-induced encephalitis in resistant C57BL/6 mice.
    Prajeeth CK, Beineke A, Iskandar CD, Gudi V, Herder V, Gerhauser I, Haist V, Teich R, Huehn J, Baumgärtner W, Stangel M.
    J Neuroinflammation; 2014 Nov 13; 11():180. PubMed ID: 25391297
    [Abstract] [Full Text] [Related]

  • 20. Relevance of Foxp3⁺ regulatory T cells for early and late phases of murine sepsis.
    Tatura R, Zeschnigk M, Hansen W, Steinmann J, Vidigal PG, Hutzler M, Pastille E, Westendorf AM, Buer J, Kehrmann J.
    Immunology; 2015 Sep 13; 146(1):144-56. PubMed ID: 26059660
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.